Name: UMIN ID:
Unique ID issued by UMIN | UMIN000021311 |
---|---|
Receipt number | R000022107 |
Scientific Title | phase 2 study of the combination therapy, docetaxel and trastuzumab, for advanced extramammary Paget's disease. |
Date of disclosure of the study information | 2016/03/03 |
Last modified on | 2023/11/16 14:56:30 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/03/03 14:46:24 | ||
2 | Update | 2016/03/11 19:50:30 | Interventions/Control_1 Interventions/Control_1 |
|
3 | Update | 2016/03/11 19:53:03 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
4 | Update | 2017/01/26 18:41:21 | Public title Acronym |
|
5 | Update | 2017/01/26 18:43:03 | Key secondary outcomes Key secondary outcomes |
|
6 | Update | 2017/01/26 19:21:50 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria Target sample size |
|
7 | Update | 2017/01/26 19:25:29 | Name of primary person or sponsor Organization Name of secondary funder(s) Name of secondary funder(s) Research ethics review |
|
8 | Update | 2017/01/26 19:26:16 | Date of protocol fixation Anticipated trial start date |
|
9 | Update | 2017/03/14 20:42:58 | Recruitment status |
|
10 | Update | 2017/06/12 22:41:45 | Recruitment status |
|
11 | Update | 2017/06/12 22:46:01 | Organization Organization Organization Category of Funding Organization Name of secondary funder(s) Name of secondary funder(s) |
|
12 | Update | 2019/12/16 20:03:28 | Recruitment status Date of IRB Last follow-up date |
|
13 | Update | 2019/12/16 20:03:55 | Number of participants that the trial has enrolled |
|
14 | Update | 2019/12/16 20:07:51 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
15 | Update | 2023/11/16 14:56:30 | Recruitment status |